Remove 2023 Remove Compounding Remove Immunity
article thumbnail

STAT+: Cancer therapy’s new ‘gold rush’:  bispecific antibodies that hit key combination of targets

STAT

Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in cancer treatment today. Opdivo, from Bristol Myers Squibb, earned $10 billion in 2023.

article thumbnail

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

Pharmacy Times

The vaccine showed superior immune response for unique serotypes compared to PPSV23, with higher OPA titers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. ACIP plays a foundational role in shaping immunization policy in the US. Kennedy Jr.

article thumbnail

Flu Vaccines Are a Go

Pharmacy Times

That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.

article thumbnail

From Pharmacy Counters to Classrooms: Building Confidence in Back-to-School Vaccinations

Pharmacy Times

Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Pharmacies enhance vaccine access and education, offering convenient vaccination opportunities and personalized counseling to counter hesitancy.

article thumbnail

RSV Vaccine Uptake Remains Low Among US Adults Aged 60 Years and Older

Pharmacy Times

Following the availability of RSV vaccines in 2023, researchers aimed to evaluate the uptake from August 2023 to February 2025 among adults aged 60 years and older, using IQVIA's open-source pharmacy (LRx) and medical (Dx) claims data.

article thumbnail

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)